Literature DB >> 10941808

Utilisation and costs of investigations, and accuracy of diagnosis of polymyalgia rheumatica by family physicians.

S Bahlas1, C Ramos-Remus, P Davis.   

Abstract

To determine the utilisation and costs of investigations, and the accuracy of polymyalgia rheumatica (PMR) by family physicians, a retrospective chart review of 123 patients referred to a tertiary care rheumatology clinic was undertaken. The accuracy of diagnosis of PMR in the cohort was 24%. A variable number of investigations and costs occurred prior to referral, ranging from $110 in those with an unspecified locomotor diagnosis, through $74 in those with a correct diagnosis of PMR, to $24 where no diagnosis was entertained. In general, these costs were considered higher than necessary to make the diagnosis compared to those advocated by rheumatologists. We conclude that there is a low accuracy of diagnosis of PMR and an overutilisation of investigations, with resultant increased costs, by family physicians referring patients with PMR. Appropriate educational interventions are required to address both diagnostic and investigational needs.

Entities:  

Mesh:

Year:  2000        PMID: 10941808     DOI: 10.1007/s100670070045

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  7 in total

Review 1.  Polymyalgia rheumatica: strategies for efficient practice and quality assurance.

Authors:  Michael Schirmer; Christian Dejaco; Bhaskar Dasgupta; Eric L Matteson
Journal:  Rheumatol Int       Date:  2015-06-02       Impact factor: 2.631

Review 2.  Polymyalgia Rheumatica.

Authors:  Miriam Giovanna Colombo; Anna-Jasmin Wetzel; Hannah Haumann; Simon Dally; Gudula Kirtschig; Stefanie Joos
Journal:  Dtsch Arztebl Int       Date:  2022-06-17       Impact factor: 8.251

3.  Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001.

Authors:  L Smeeth; C Cook; A J Hall
Journal:  Ann Rheum Dis       Date:  2006-01-13       Impact factor: 19.103

4.  The rate of polymyalgia rheumatica (PMR) and remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome in a clinic where primary care physicians are working in Japan.

Authors:  Toshikatsu Okumura; Satoshi Tanno; Masumi Ohhira; Tsukasa Nozu
Journal:  Rheumatol Int       Date:  2011-03-24       Impact factor: 2.631

5.  Challenges of diagnosing and managing polymyalgia rheumatica: a multi-methods study in UK general practice.

Authors:  Toby Helliwell; Sara Muller; Samantha L Hider; Irena Zwierska; Sarah Lawton; Jane Richardson; Christian Mallen
Journal:  Br J Gen Pract       Date:  2018-11       Impact factor: 5.386

6.  Polymyalgia rheumatica: diagnosis, prescribing, and monitoring in general practice.

Authors:  Toby Helliwell; Samantha Lara Hider; Christian David Mallen
Journal:  Br J Gen Pract       Date:  2013-05       Impact factor: 5.386

7.  Balancing on the edge: implications of a UK national audit of the use of BSR-BHPR guidelines for the diagnosis and management of polymyalgia rheumatica.

Authors:  Parthajit Das; Ash Samanta; Bhaskar Dasgupta
Journal:  RMD Open       Date:  2015-07-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.